FlexiLoans scale grew 58% in FY22 with controlled losses

FlexiLoans scale grew 58% in FY22 with controlled losses

Fintech lender focused on small and medium enterprises, FlexiLoans had recently raised $90 million in a Series B round with plans to strengthen and broaden its lending base, scale its BNPL (buy now pay later) platform, expand its partner ecosystem, and create new product category offerings.

It is Real Valium online also essential to Trusted site to Buy Tramadol recognize that the journey through detoxification and recovery is unique for each person. For those dealing with chronic pain conditions like osteoarthritis, the decision-making process Pregabalin Legally Ambien No Rx can become even more complicated. The How To Buy Xanax Online transition from protecting oneself to living in a state of heightened caution can create barriers to engaging fully in life, fostering an environment ripe Purchase Xanax Without Prescription for apathy to take hold. This is particularly Ultram Overnight concerning for older adults, who often take multiple medications for various Tramadol Online chronic conditions. Traditionally, treatment focused Xanax Discount primarily on pain relief through Xanax Next Day Delivery medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids. In this journey, effective communication, education, and support are vital components for fostering Buy Soma Online a healthcare Ambien 10 Mg Price environment that prioritizes patient-centered care. As such, discussing productivity in the context of managing Order Ambien Online conditions like breakthrough Buy Klonopin Online Overnight pain reflects a broader understanding of what it means to be truly productive. Concurrently, Ambien Online the use Xanax Overnight Shipping of analgesics for managing anxiety-related symptoms has seen a notable uptick. Healthcare providers can Trusted site to Buy Soma play a vital role in Valium No Rx this process by discussing financial concerns with patients openly and exploring potential solutions together.

While the impact of this round on the FlexiLoans scale will be ascertained in the next couple of years, the firm’s scale soared over 58% to Rs 51.5 crore in FY22, as per its annual financial statements filed with the Registrar of Companies .

 

Founded by Deepak Jain, Manish Lunia, Ritesh Jain and Abhishek Kothari, FlexiLoans offers term loans, loans against point-of-sale (POS), lines of credit, and vendor financing. The seven-year-old company claims to have disbursed loans worth over Rs 1,700 crore across 1,600 Indian cities and has managed to keep its non-performing assets below 4%. 

On the expense side, employee benefits expense emerged as the largest cost for the company, contributing 24.3% to the total annual expenditure. This cost surged 15.6% to Rs 17.14 crore in FY22 from Rs 14.83 crore in FY21.

 

Finance cost was found to be the second major cost and formed 21.4% of the total expenses. The cost increased 31.4% to nearly Rs 15 crore during FY22.

FlexiLoans also incurred commission (paid to the selling agents) and advertising/promotional expenses that shot up 3.3X and 3.2X to Rs 4.11 crore and Rs 3.45 crore respectively in FY22.  Importantly, the company booked Rs 12.2 crore as a provision for bad or doubtful debts during FY22.

In total, the annual expenditure of the company soared 46% to Rs 70.4 crore in FY22 as compared to Rs 48.2 crore in FY21.

The growth in scale helped the company to squeeze losses by 34.7% to Rs 10.8 crore in the last fiscal year from Rs 16.53 crore in FY21. During FY22, the company also improved its unit economics and spent Rs 1.37 to earn a rupee of operating revenue.

 

With improved economics, FlexiLoans also refined ratios: EBITDA Margin and ROCE bettered to 5.01% and -1.80% in FY22 from 3.92% and -2.31% in FY21.

Source @Entrackr

Leave a Reply